SKI Market

A+| A| A-|

Indian Indices

Sensex

73,319.55 185.23
( 0.25%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

State Bank of India

Industry : Banks - Public Sector

BSE Code

ISIN Demat

Book Value()

500112

INE062A01020

555.3957794

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

SBIN

12.46

941015.31

EPS(TTM)

Face Value()

Div & Yield %

81.79

1.51

Back

Transgene Biotek reports consolidated net loss of Rs 0.37 crore in the December 2025 quarter

Feb 13,2026

Net Loss of Transgene Biotek reported to Rs 0.37 crore in the quarter ended December 2025 as against net loss of Rs 0.09 crore during the previous quarter ended December 2024. Sales declined 37.50% to Rs 0.05 crore in the quarter ended December 2025 as against Rs 0.08 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0.05	0.08	-38
OPM %	-100.00	-112.50	-
PBDT	-0.32	-0.07	-357
PBT	-0.37	-0.09	-311
NP	-0.37	-0.09	-311

73,319.55 185.23 ( 0.25%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)